U.S. Markets closed

Quidel Corporation (QDEL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
32.61+0.14 (+0.43%)
At close: 4:00PM EDT
People also watch
VIVOQGENOSURVICLABAX

Quidel Corporation

12544 High Bluff Drive
Suite 200
San Diego, CA 92130
United States
858-552-1100
http://www.quidel.com

SectorHealthcare
IndustryDiagnostic Substances
Full Time Employees627

Key Executives

NameTitlePayExercisedAge
Mr. Douglas C. BryantChief Exec. Officer, Pres and Director960.05k1.99M59
Mr. Randall J. StewardChief Financial Officer531.08kN/A63
Mr. Robert J. Bujarski J.D.Sr. VP of Bus. Devel., Gen. Counsel and Corp. Sec.524.15k373.36k49
Mr. Werner Kroll Ph.D.Sr. VP of R&D508.23kN/A60
Mr. Edward Keith RussellSr. VP of Global Commercial Operations524.08kN/A49
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women’s and general health, and gastrointestinal diseases. The company offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus (RSV), QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S. Pneomoniae fluorescent immunoassay (FIA) to detect pneumococcal pneumonia and meningitis; Sofia Legionella FIA to detect Legionella pneumophila seorgroup 1 antigen; AmpliVue Bordetella assay to detect Bordetella pertussis; and Lyra Adenovirus assay to detect human adenovirus viral DNA. In addition, the company offers Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests to detect hCG in serum or urine; Thyretain for the diagnosis of graves disease; QuickVue Chlamydia test to detect Chlamydia trachomatis; Solana Trichomonas assay for the diagnosis of trichomoniasis; and clinical and research products for the assessment of osteoporosis and evaluation of bone resorption/formation. Further, it provides Lyra Direct C. difficile assay to detect Clostridium difficile Toxin A or Toxin B genes; Super E-Mix and D3 IFA Enterovirus indirect fluorescent antibody products; QuickVue fecal immunochemical test to detect the presence of blood in stool specimens; and serological tests to measure antibodies circulating in the blood. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Corporate Governance

Quidel Corporation’s ISS Governance QualityScore as of August 1, 2017 is 2. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.